Associations between tumor necrosis factor-α polymorphisms and risk of psoriasis: A meta-analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Zhuang, Le ^a   Ma, Weiyuan ^a   Cai, Daxing ^a   Zhong, Hua ^a   Sun, Qing ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; GUANIDINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; DATA ANALYSIS; DISEASE ASSOCIATION; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; POPULATION RESEARCH; PSORIASIS; RISK REDUCTION; SYSTEMATIC REVIEW; TNFALPHA 238 GENE; TNFALPHA 308 GENE;

CASE-CONTROL STUDIES; DATABASES, BIBLIOGRAPHIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PSORIASIS; RISK; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84891919435     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068827     Document Type: Article

References (36)

1. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361 (5): 496-509. doi:10.1056/NEJMra0804595. PubMed: 19641206.
2. Menter A, Griffiths CE (2007) Current and future management of psoriasis. Lancet 370 (9583): 272-284. doi:10.1016/ S0140-6736(07)61129-5. PubMed: 17658398. (Pubitemid 47071926)
3. Valdimarsson H, Thorleifsdottir RH, Sigurdardottir SL, Gudjonsson JE, Johnston A (2009) Psoriasis-as an autoimmune disease caused by molecular mimicry. Trends Immunol 30 (10): 494-501. doi:10.1016/j.it. 2009.07.008. PubMed: 19781993.
4. Nickoloff BJ, Nestle FO (2004) Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J Clin Invest 113 (12): 1664-1675. doi:10.1172/ JCI200422147. PubMed: 15199399. (Pubitemid 39071656)
5. Roberson ED, Bowcock AM (2010) Psoriasis genetics: breaking the barrier. Trends Genet 26 (9): 415-423. doi:10.1016/j.tig.2010.06.006. PubMed: 20692714.
6. Stuart PE, Nair RP, Ellinghaus E, Ding J, Tejasvi T et al. (2010) Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet 42 (11): 1000-1004. doi:10.1038/ng.693. PubMed: 20953189.
7. Lee YH, Choi SJ, Ji JD, Song GG (2012) Genome-wide pathway analysis of a genome-wide association study on psoriasis and Behcet's disease. Mol Biol Rep 39 (5): 5953-5959. doi:10.1007/ s11033-011-1407-9. PubMed: 22201026.
8. Bos JD, De Rie MA (1999) The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 20 (1): 40-46. doi:10.1016/S0167-5699(98) 01381-4. PubMed: 10081229. (Pubitemid 29136549)
9. Bowcock AM (2005) The genetics of psoriasis and autoimmunity. Annu Rev Genomics Hum Genet 6: 93-122. doi:10.1146/annurev.genom. 6.080604.162324. PubMed: 16124855. (Pubitemid 41397077)
10. Falvo JV, Tsytsykova AV, Goldfeld AE (2010) Transcriptional control of the TNF gene. Curr Dir Autoimmun 11: 27-60. doi:10.1159/000289196. PubMed: 20173386.
11. Reich K, Westphal G, Schulz T, Müller M, Zipprich S et al. (1999) Combined analysis of polymorphisms of the tumor necrosis factoralpha and interleukin-10 promoter regions and polymorphic xenobiotic metabolizing enzymes in psoriasis. J Invest Dermatol 113 (2): 214-220. doi:10.1046/j.1523-1747.1999. 00654.x. PubMed: 10469306. (Pubitemid 30202525)
12. Reich K, Mössner R, König IR, Westphal G, Ziegler A et al. (2002) Promoter polymorphisms of the genes encoding tumor necrosis factoralpha and interleukin-1beta are associated with different subtypes of psoriasis characterized by early and late disease onset. J Invest Dermatol 118 (1): 155-163. doi:10.1046/j.0022-202x.2001.01642.x. PubMed: 11851889. (Pubitemid 34107437)
13. Mössner R, Kingo K, Kleensang A, Krüger U, König IR et al. (2005) Association of TNF -238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. J Invest Dermatol 124 (1): 282-284. doi:10.1111/j. 0022-202X.2004.23556.x. PubMed: 15654990. (Pubitemid 40100984)
14. Magalhaes RF, Biral AC, Pancoto JA, Donadi EA, Mendes CT Jr. et al. (2010) Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha -238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian study. Int J Dermatol 49 (10): 1133-1140. doi:10.1111/j.1365-4632. 2010.04465.x. PubMed: 20931685.
15. González S, Brautbar C, Martínez-Borra J, López-Vazquez A, Segal R et al. (2001) Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol 62 (6): 632-638. doi:10.1016/S0198-8859(01)00242-7. PubMed: 11390038. (Pubitemid 32506181)
16. Tsunemi Y, Nishibu A, Saeki H, Oyama N, Nakamura K et al. (2003) Lack of association between the promoter polymorphisms at positions -308 and -238 of the tumor necrosis factor alpha gene and psoriasis vulgaris in Japanese patients. Dermatology 207 (4): 371-374. doi: 10.1159/000074117. PubMed: 14657629. (Pubitemid 37505785)
17. Nedoszytko B, Szczerkowska-Dobosz A, Zab?otna M, Gleń J, Reba?a K et al. (2007) Associations of promoter region polymorphisms in the tumour necrosis factor-alpha gene and early-onset psoriasis vulgaris in a northern Polish population. Br J Dermatol 157 (1): 165-167. doi: 10.1111/j.1365-2133. 2007.07993.x. PubMed: 17553030. (Pubitemid 46934284)
18. Craven NM, Jackson CW, Kirby B, Perrey C, Pravica V et al. (2001) Cytokine gene polymorphisms in psoriasis. Br J Dermatol 144 (4): 849-853. doi:10.1046/j.1365-2133.2001.04143.x. PubMed: 11298547. (Pubitemid 32374791)
19. Kim TG, Pyo CW, Hur SS, Kim YK, Hwang HY et al. (2003) Polymorphisms of tumor necrosis factor (TNF) alpha and beta genes in Korean patients with psoriasis. Arch Dermatol Res 295 (1): 8-13. PubMed: 12709814.
20. Baran W, Szepietowski JC, Mazur G, Baran E (2006) A - 308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients. Acta Dermatovenerol Alp Panonica Adriat 15 (3): 113-118. PubMed: 17053845. (Pubitemid 44546082)
21. Salanti G, Amountza G, Ntzani EE, Ioannidis JP (2005) Hardy- Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet 13 (7): 840-848. doi:10.1038/sj.ejhg.5201410. PubMed: 15827565. (Pubitemid 40946083)
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327 (7414): 557-560. doi: 10.1136/bmj.327.7414.557. PubMed: 12958120. (Pubitemid 37088507)
23. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (4): 719-748. PubMed: 13655060.
24. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7 (3): 177-188. doi:10.1016/0197-2456(86)90046-2. PubMed: 3802833. (Pubitemid 17189972)
25. Tobias A (1999) Assessing the influence of a single study in the metaanalysis estimate 8. Stata Tech Bull. pp. 15-17.
26. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315 (7109): 629-634. doi:10.1136/bmj.315.7109.629. PubMed: 9310563. (Pubitemid 27387172)
27. Gallo E, Cabaleiro T, Román M, Abad-Santos F, Daudén E (2012) Study of genetic polymorphisms in the tumor necrosis factor alpha promoter region in Spanish patients with psoriasis. Actas Dermosifiliogr 103 (4): 301-307. doi:10.1016/j.ad.2011.10.002. PubMed: 22188951.
28. Rahman P, Siannis F, Butt C, Farewell V, Peddle L et al. (2006) TNFalpha polymorphisms and risk of psoriatic arthritis. Ann Rheum Dis 65 (7): 919-923. PubMed: 16284098.
29. Reich K, Hüffmeier U, König IR, Lascorz J, Lohmann J et al. (2007) TNF polymorphisms in psoriasis: association of psoriatic arthritis with the promoter polymorphism TNF857 independent of the PSORS1 risk allele. Arthritis Rheum 56 (6): 2056-2064. doi:10.1002/art.22590. PubMed: 17530646. (Pubitemid 47110405)
30. Long F, Sun C, Deng D, Zhou X, Li XP et al. (2004) TNF-238A is associated with juvenile onset psoriasis in patients of Han population in Southwest China. J Dermatol Sci 36 (2): 109-111. doi:10.1016/ j.jdermsci.2004.08.004. PubMed: 15519142. (Pubitemid 39424135)
31. Kaluza W, Reuss E, Grossmann S, Hug R, Schopf RE et al. (2000) Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 114 (6): 1180-1183. doi:10.1046/j. 1523-1747.2000.00001.x. PubMed: 10844563. (Pubitemid 30415236)
32. Al-Heresh AM, Proctor J, Jones SM, Dixey J, Cox B et al. (2002) Tumour necrosis factor-alpha polymorphism and the HLA-Cw*0602 allele in psoriatic arthritis. Rheumatology (Oxford) 41 (5): 525-530. doi: 10.1093/rheumatology/41. 5.525. PubMed: 12011375. (Pubitemid 34567182)
33. Jacob N, Rüschendorf F, Schmitt-Egenolf M, Hennies HC, Friedl G et al. (2009) Promoter polymorphism at -238 of the tumor necrosis factor alpha gene is not associated with early onset psoriasis when tested by the transmission disequilibrium test. J Invest Dermatol 112(4): 514-516.
34. Chandran V, Raychaudhuri SP (2010) Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun 34 (3): J314-J321. doi:10.1016/j.jaut.2009.12.001. PubMed: 20034760.
35. Lee YH, Choi SJ, Ji JD, Song GG (2012) Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a metaanalysis. Inflamm Res 61 (7): 657-663. doi:10.1007/ s00011-012-0458-2. PubMed: 22427230.
36. Riveira-Munoz E, He SM, Escaramís G, Stuart PE, Hüffmeier U et al. (2011) Meta-analysis confirms the LCE3C-LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6. J Invest Dermatol 131 (5): 1105-1109. doi:10.1038/jid. 2010.350. PubMed: 21107349.